COVID-19-associated encephalitis or Creutzfeldt-Jakob disease: a case report

Neurodegener Dis Manag. 2022 Feb;12(1):29-34. doi: 10.2217/nmt-2021-0025. Epub 2021 Dec 2.

Abstract

Background: Accurate diagnosis and management of patients with rapidly progressive dementia may be challenging during the COVID-19 pandemic, which has negatively influenced the diagnostic performances, medical resource allocation and routine care for all non-COVID-19 diseases. Case presentation: We herein present a case of a 57-year-old male with rapidly progressive cognitive decline, headache, diplopia, myalgia, unsteady gait, aggression, depression, insomnia, hallucinations and delusions of persecution. COVID-19-associated encephalitis was briefly considered as a differential diagnosis. However, this hypothesis was rejected upon further investigation. A final diagnosis of sporadic Creutzfeldt-Jakob disease was made. Conclusion: A timely and accurate diagnosis of Creutzfeldt-Jakob disease gives patients and their families the chance to receive a good standard of healthcare and avoid extensive evaluations for other conditions.

Keywords: COVID-19; Creutzfeldt–Jakob disease; SARS-CoV-2; coronavirus; encephalitis; prion diseases.

Publication types

  • Case Reports

MeSH terms

  • COVID-19 / complications*
  • COVID-19 / epidemiology
  • Creutzfeldt-Jakob Syndrome / complications*
  • Creutzfeldt-Jakob Syndrome / diagnosis*
  • Diagnosis, Differential
  • Encephalitis / complications*
  • Encephalitis / diagnosis*
  • Humans
  • Male
  • Middle Aged
  • Pandemics